MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
81.39
+1.05
+1.30%
After Hours: 81.46 +0.07 +0.09% 19:31 11/12 EST
OPEN
80.99
PREV CLOSE
80.35
HIGH
82.51
LOW
79.38
VOLUME
4.09M
TURNOVER
--
52 WEEK HIGH
92.59
52 WEEK LOW
54.20
MARKET CAP
30.35B
P/E (TTM)
31.98
1D
5D
1M
3M
1Y
5Y
1D
Is DexCom (DXCM) Reasonably Priced After Raised Guidance And G7 Progress?
Simply Wall St · 2h ago
Pregnancy Device Approval Could Be A Big Deal For DexCom (DXCM)
Simply Wall St · 1d ago
Is DexCom (DXCM) Still Below Fair Value As Guidance Rises And Buybacks Begin?
Simply Wall St · 2d ago
Tracking Baillie Gifford's 13F Portfolio - Q3 2026 Update
Seeking Alpha · 3d ago
Weekly Report: what happened at DXCM last week (1102-1106)?
Weekly Report · 3d ago
DexCom Inc. Stock Sheds 6.0%, Underperforms Market
Dow Jones · 6d ago
Insulet Corp. Stock Sheds 6.2%, Underperforms Peers
Dow Jones · 6d ago
DexCom Stock Has The Bull Case Changed After The Canada Launch And Guidance Raise
Simply Wall St · 11/04 21:32
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.